Taken together, our data suggested that lncRNA SNHG1 could promote NSCLC progression via miR-101-3p and SOX9, and that Wnt/β-catenin signaling pathway was involved in the regulatory mechanism. The gene discussed is SNHG1; the disease is non-small cell lung carcinoma.